These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4200376)

  • 41. [Protective mechanisms in hemolytic disease of the newborn. (Rhesus system)].
    Gonzalez Ramos M
    Ginecol Obstet Mex; 1966; 21(123):469-75. PubMed ID: 4967226
    [No Abstract]   [Full Text] [Related]  

  • 42. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn].
    Holtorff J; Brey J; Nitzsche M
    Zentralbl Gynakol; 1969 May; 91(20):629-47. PubMed ID: 4984542
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hematologic diagnosis of hemolytic disease of the newborn].
    Martín Villar J; Navarro Navarro JL
    Acta Obstet Ginecol Hisp Lusit; 1968; 16(4):285-93. PubMed ID: 4988904
    [No Abstract]   [Full Text] [Related]  

  • 44. [Fetal-maternal leakage as 1 of the causes of the pathogenesis of hemolytic disease in the newborn].
    Dziekan L
    Przegl Lek; 1971; 27(2):196-9. PubMed ID: 4994371
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother.
    Kanra T; Erdoğan S; Yurdakök M; Erdem G
    Turk J Pediatr; 1983; 25(2):129-33. PubMed ID: 6422599
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hemolytic disease of newborn due to sensitization of the mother with antigen Cw].
    Gatniejewska-Komraus M; Seyfriedowa H
    Pediatr Pol; 1972 Oct; 47(10):1275-7. PubMed ID: 4628599
    [No Abstract]   [Full Text] [Related]  

  • 47. [Placenta and maternal and fetal iso-immunization].
    von Muralt G
    Geburtshilfe Frauenheilkd; 1972 Feb; 32(2):81-8. PubMed ID: 4622621
    [No Abstract]   [Full Text] [Related]  

  • 48. [Occurrence of hemolytic disease of the newborn caused by irregular antibodies].
    Mickley H
    Ugeskr Laeger; 1983 Jun; 145(23):1763-5. PubMed ID: 6410568
    [No Abstract]   [Full Text] [Related]  

  • 49. Risky grandmothers in Rh disease.
    Br Med J; 1967 Aug; 3(5561):322-3. PubMed ID: 4961640
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical follow-up on late prognosis of Rh-related hemolytic disease of the newborn].
    Schneeweiss B; Klemm PG; Matz J; Müller K; Olbrich G; Otto FM; Solyga P
    Padiatr Grenzgeb; 1970; 9(3):149-56. PubMed ID: 4997627
    [No Abstract]   [Full Text] [Related]  

  • 51. [Possibility of errors in the determination of the genotype Rh in newborn infants with fetal erythroblastosis].
    Cavallini R
    Riv Emoter Immunoematol; 1968; 15(3):83-8. PubMed ID: 4980459
    [No Abstract]   [Full Text] [Related]  

  • 52. [Titers and hemolytic late effects of rhesus antibodies in exchange transfusion in newborn infants with hemolytic anemia due to the rhesus factor].
    Ruckstuhl J
    Helv Paediatr Acta; 1970 Jul; 25(3):258-72. PubMed ID: 4996413
    [No Abstract]   [Full Text] [Related]  

  • 53. [Action of various substrates on the spontaneous in vitro hemolysis of erythrocytes in hemolytic disease of the Rh and ABO newborn infant].
    Schettini F; Violante N; Mautone A
    Minerva Pediatr; 1969 Feb; 21(5):186-90. PubMed ID: 4975718
    [No Abstract]   [Full Text] [Related]  

  • 54. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.
    Hinz CF; Picken ME; Lepow IH
    J Exp Med; 1961 Jan; 113(1):193-218. PubMed ID: 19867184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABO hemolytic disease, complement, and phagocytosis.
    Gordon BD; Desforges J
    Pediatrics; 1972 Jul; 50(1):169. PubMed ID: 5038101
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rh and ABO incompatibility].
    Brandl K
    Wien Klin Wochenschr; 1965 Oct; 77(42):814-5. PubMed ID: 4956671
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunologic examination in cases of death of the fetus due to hemolytic disease of the newborns].
    Kulich V; Pribilová A; Havránek E
    Cesk Gynekol; 1971 Apr; 36(3):136-9. PubMed ID: 4996773
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hemolytic disease of the newborn due to anti-e antibodies].
    Vulcheva B; Spasova K; Doĭcheva E
    Akush Ginekol (Sofiia); 1979; 18(1):19-21. PubMed ID: 107824
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rh-sensitization of newborn infants through dissonant materno-fetal transfusion].
    Hindemann P; Modly T
    Gynakol Rundsch; 1973; 13():Suppl 1:109-11. PubMed ID: 4206289
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.